Synonym:
5-Acetamido-1,3,4-thiadiazole-2-sulfonamide,
N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide,
N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide
Properties:
| Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards A - B,
Pharmacopeia & Metrological Institutes Standards
|
Description:
Application
Carbonic anhydrase inhibitor; increases cerebral blood flow.
Caution
Please find SDS provided by EDQM here.
.
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia
.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference subtance catalogue
.
Biochem/physiol Actions
Inhibits water permeability of membranes by interacting with aquaporins
Safety:
Symbol

GHS07
Hazard statements
H315-H319
Precautionary statements
P305 + P351 + P338
RIDADR
NONH for all modes of transport